| 2D Structure | |
| CID | 64710 |
| IUPAC Name | (2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride |
| InChI | InChI=1S/C18H34N2O6S.ClH/c1-5-6-10-7-11(20(3)8-10)17(25)19-12(9(2)21)16-14(23)13(22)15(24)18(26-16)27-4;/h9-16,18,21-24H,5-8H2,1-4H3,(H,19,25);1H/t9-,10-,11+,12-,13+,14-,15-,16-,18-;/m1./s1 |
| InChI Key | POUMFISTNHIPTI-BOMBIWCESA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C18H35ClN2O6S |
| Molecular Weight | 443.0 |
| synonyms | ['Lincomycin hydrochloride', '859-18-7', 'LINCOMYCIN HCL', 'Lincomix 20', 'Lincomycin hydrochloride anhydrous', 'Lincomix', 'GCW8Y9936L', 'DTXSID7047803', 'Lincomycin soluble', 'Lincolnensin hydrochloride', 'DTXCID9027780', 'Lincomycin hydrochloride anhdrous', 'D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, monohydrochloride, (2S-trans)-', 'NSC70731', 'NSC-70731', 'NSC-757092', 'Linco Soluble', 'LinxMed-SP', 'Lincomix 50', 'LincoBac 300', 'LincoMed 100', 'Lincosol Soluble Powder', 'RefChem:582700', 'LINCOMIX Soluble Powder', 'LINCOMYCIN 300', 'LincoMed 100, LincoMed 300', 'Lincomycin Hydrochloride Soluble Powder', '212-726-7', 'methyl 6,8-dideoxy-6-(((4R)-1-methyl-4-propyl-L-prolyl)amino)-1-thio-D-erythro-alpha-D-galacto-octopyranoside hydrochloride anhydrous', 'Lincolnensin hydrochloride monohydrate', 'Lincomycin (as hydrochloride)', 'Lincomycin hydrochloride usp', 'M6T05Z2B68', 'Frademicina', 'Lincocin', 'MFCD00083647', 'Mycivin', 'Lincomycin HCl (Lincocin)', 'Lincomycin (hydrochloride)', '(2S,4R)-N-((1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride', 'Pura Ject 100', 'NCGC00159326-02', 'Lincolnensin, hydrochloride', 'NSC 70731', 'C18H35ClN2O6S', 'Antibiotic 124a, hydrochloride', 'Lincogap', 'U 10149a', 'Lincocin Hydrochloride', '(2S,4R)-N-{(1S)-2-hydroxy-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-tetrahydro-2H-2-pyranyl]propyl}-1-methyl-4-propylpyrrolidine-2-carboxamide Hydrochloride', 'UNII-GCW8Y9936L', 'Lincomycin (hydrochloride hydrate)', 'EINECS 212-726-7', 'CAS-859-18-7', 'EC 212-726-7', 'Lincomycin Monohydrochloride', 'Lincomycin hydrochloride CRS', 'SCHEMBL192964', 'MSK7802A', 'orb1309148', 'HY-B0417A', 'MSK7802A-100M', 'MSK7802A-1000M', 'Tox21_111575', 'EBC-11104', 'MFCD22631533', 'AKOS024375415', 'Tox21_111575_1', 'AL16775', 'CCG-220302', 'ANHYDROUS LINCOMYCIN HYDROCHLORIDE', 'LINCOMYCIN HYDROCHLORIDE [WHO-DD]', 'NCGC00159326-03', '(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride', 'AS-13720', 'Lincomycin hydrochloride, >=90% (TLC)', 'SY006929', 'Lincomycin hydrochloride, >=95.0% (TLC)', 'L0166', 'NS00076397', 'ST51016093', 'LINCOMYCIN HYDROCHLORIDE ANHDROUS [MI]', 'Lincomycin hydrochloride for system suitability', 'EN300-6494894', 'ANHYDROUS LINCOMYCIN HYDROCHLORIDE [MART.]', 'Lincomycin hydrochloride for system suitability CRS', 'Q27279041', 'Lincomycin hydrochloride Solution in Methanol, 100ug/mL', 'Lincomycin hydrochloride Solution in Methanol, 1000ug/mL', 'Lincomycin hydrochloride, BioReagent, suitable for cell culture', 'Lincomycin hydrochloride, British Pharmacopoeia (BP) Reference Standard', '(2s,4r)-N-[(1r,2r)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboximidic acid hydrochloride', '(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide;hydrochloride', '(2S,4R)-N-[(1R,2R)-2-Hydroxy-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-tetrahydro-2H-2-pyranyl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide Hydrochloride', '(2S-TRANS)-METHYL 6,8-DIDEOXY-6-(((1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-THIO-D-ERYTHRO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE HYDROCHLORIDE', 'D-ERYTHRO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE, METHYL 6,8-DIDEOXY-6-(((1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-THIO-, MONOHYDROCHLORIDE, (2S-TRANS)-', 'D-erythro-.alpha.-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, hydrochloride (1:1)', 'D-erythro-|A-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, hydrochloride (1:1)', 'D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-((((2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, monohydrochloride', 'D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, hydrochloride (1:1)', 'D-erythro-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, monohydrochloride, trans-alpha-', 'Methyl (2S-trans)-6,8-dideoxy-6-(((1-methyl-4-propylpyrrolidin-2-yl)carbonyl)amino)-1-thio-D-erythro-alpha-D-galacto-octopyranoside monohydrochloride', 'METHYL 6,8-DIDEOXY-6-(1-METHYL-TRANS-4-PROPYL-L-2-PYRROLIDINECARBOXAMIDO)-1-THIO-D-ERYTHRO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE MONOHYDROCHLORIDE', 'Methyl 6,8-dideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-D-erythro-alpha-D-galacto-octopyranoside--hydrogen chloride (1/1)', 'N-[(1R,2R)-1-((4S,2R,3R,5R,6R)-3,4,5-trihydroxy-6-methylthio(2H-3,4,5,6-tetrah ydropyran-2-yl))-2-hydroxypropyl]((2S,4R)-1-methyl-4-propylpyrrolidin-2-yl)car boxamide, chloride'] |
From Pubchem